MARKET

MNMD

MNMD

Mind Medicine
NASDAQ
13.46
+0.40
+3.06%
After Hours: 13.37 -0.09 -0.65% 19:48 12/29 EST
OPEN
13.10
PREV CLOSE
13.06
HIGH
13.54
LOW
13.01
VOLUME
1.14M
TURNOVER
--
52 WEEK HIGH
14.43
52 WEEK LOW
4.700
MARKET CAP
1.33B
P/E (TTM)
-6.8259
1D
5D
1M
3M
1Y
5Y
1D
MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026?
NASDAQ · 14h ago
Weekly Report: what happened at MNMD last week (1222-1226)?
Weekly Report · 19h ago
Ametek, MindMed, Atai, Prime and KB Home Trending
TipRanks · 2d ago
MindMed Expands Into Autism: What Investors Should Know About the New MM402 Trial
TipRanks · 3d ago
Is MindMed (MNMD) Turning Psychedelic Policy Tailwinds Into a Durable Neuropsychiatry Advantage?
Simply Wall St · 4d ago
Wall Street Thinks This 1 Psychedelic Stock Can Gain 335% in 2026
Barchart · 4d ago
Midday Fly By: Wegovy weight loss pill approved, ServiceNow inks security deal
TipRanks · 6d ago
Coty downgraded, Spruce Biosciences initiated: Wall Street’s top analyst calls
TipRanks · 6d ago
More
About MNMD
Mind Medicine (MindMed) Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. The Company is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, its lead product candidates. Its lead product candidate, MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that the Company is developing for the treatment of generalized anxiety disorder and major depressive disorder. Its second lead product candidate, MM402, also referred to as R(-)-MDMA, is its proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

Webull offers Mind Medicine (MindMed) Inc stock information, including NASDAQ: MNMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MNMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MNMD stock methods without spending real money on the virtual paper trading platform.